Capmatinib

TABRECTA (capmatinib) is an oral prescription medication from Novartis Pharmaceuticals Corporation, approved to treat adults with metastatic non-small cell lung...TABRECTA（卡马替尼capmatinib）是诺华制药股份有限公司（Novartis Pharmaceuticals Corporation）旗下的口服处方药物，已获批用于治疗成人转移性非小细胞肺癌……